ImageneBio logo

ImageneBio

IMA | NASDAQ
Chart Builder DCF Calculator
$3.20
-$0.27 (-7.78%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-7.78%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #910/1021 (Top 89%)

Key Statistics

Market Data

Market Cap $54.79M
1D Range
3.13 3.36
52W Range
3.13 7.70

Valuation (TTM)

PE -1.03
PB 0.43
EV/EBITDA 1.60

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $1.33
Loading financial charts...

Profile

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, ...

Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Feb 27, 1998
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Sell
Price Target
$1.33
Downside
-58.44%
Buy (0)
Hold (0)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.